| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/25/2013 | CA2492097C Signal for packaging of influenza virus vectors |
| 06/25/2013 | CA2454578C Modified human thymic stromal lymphopoietin |
| 06/25/2013 | CA2446110C A system for inducible expression in eukaryotic cells |
| 06/25/2013 | CA2366211C Hyphal growth in fungi |
| 06/20/2013 | WO2013090318A1 Utility of insulin-like 6 (insl6) for the treatment of autoimmune diseases |
| 06/20/2013 | WO2013088587A1 Recombinant protein capable of binding to troponin-i from human cardiac muscle specifically and rapidly |
| 06/20/2013 | WO2013070615A8 Combination therapies using anti- pseudomonas psl and pcrv binding molecules |
| 06/20/2013 | WO2013063613A3 Methods and compositions related to intracellular neutralization by igg |
| 06/20/2013 | WO2012071366A8 Stable preserved compositions of interferon-beta |
| 06/20/2013 | WO2008045970A9 Compositions and methods of using chondroitinase abci mutants |
| 06/20/2013 | US20130158239 Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose |
| 06/20/2013 | US20130157872 In vitro evolution in microfluidic systems |
| 06/20/2013 | US20130157342 Novel aldolase and production process of substituted alpha-keto acids |
| 06/20/2013 | US20130156862 Extracellular Matrix-Derived Gels and Related Methods |
| 06/20/2013 | US20130156801 Compositions and methods for exosome targeted expression |
| 06/20/2013 | US20130156775 Chlamydia trachomatis antigens |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases |
| 06/20/2013 | US20130153733 Extendable/retractable support column |
| 06/20/2013 | US20130153419 Generation of engineered molecular weight standards |
| 06/19/2013 | EP2605013A1 Stimulation of pancreatic beta-cell proliferation |
| 06/19/2013 | EP2604626A1 Fragment of humanized anti-egfr antibody substituted-lysine variable fragment and use thereof |
| 06/19/2013 | EP2603600A2 Peptidomimetic macrocycles |
| 06/19/2013 | CN1798834B Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon |
| 06/19/2013 | CN103168104A Anti-tumor antigen antibodies and methods of use |
| 06/19/2013 | CN103168047A Polypeptide associated with the synthesis of 1-deoxynojirimycin, and a use therefor |
| 06/19/2013 | CN103167879A Dual variable domain immunoglobulins and uses thereof |
| 06/19/2013 | CN103160559A Preparation method of modified zein peptide |
| 06/19/2013 | CN103160558A Method for preparing lactalbumin hydrolysate |
| 06/19/2013 | CN103160557A Purpose of ribosomal protein S5 in catalyzing of protein molecules for generatation of dephosphorylation reaction |
| 06/19/2013 | CN103160556A Application of Streptomyces parvus |
| 06/19/2013 | CN103160555A Culture medium, culture method and application of high-yield exotoxin of clostridium perfringens |
| 06/19/2013 | CN103160283A Heavy metal pollution prothetic composition of soil and water body and application |
| 06/19/2013 | CN103159857A Compound based on recombinational triple helix support |
| 06/19/2013 | CN103159847A Natriuretic peptide, as well as gene and use thereof |
| 06/19/2013 | CN103159830A Lipopeptide compounds |
| 06/19/2013 | CN102719421B Marine bacteria cold-adapted protease and encoding gene and application thereof |
| 06/19/2013 | CN102286369B Microorganism fermentation process scaling-up platform technique |
| 06/19/2013 | CN102251005B Preparation method of royal jelly polypeptide |
| 06/19/2013 | CN102212126B Recombinant EDI (Endothelial Genesis Inhibitor)-8t protein with endothelial cell growth inhibiting activity |
| 06/19/2013 | CN102127167B Whole human TNF alpha (tumor necrosis factor alpha) monoclonal antibody and preparation and application thereof |
| 06/19/2013 | CN102115690B Method for comprehensively utilizing rice bran |
| 06/19/2013 | CN102086465B Method for preparing polypeptide active substance from enzymolysis ginkgo protein |
| 06/19/2013 | CN101970462B Cyclic compound and salt thereof |
| 06/19/2013 | CN101899116B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 06/19/2013 | CN101874041B Modified antibody constant region |
| 06/19/2013 | CN101781642B Culture medium for identifying differential protein components in Trichoderma koningii cellulose system and application thereof |
| 06/19/2013 | CN101609097B Competitive enzyme-linked immunosorbent assay method of EV71 neutralizing antibody, kit or reagent and prepration method thereof |
| 06/19/2013 | CN101580538B WT1-origin HLA-DR-binding antigen peptide |
| 06/19/2013 | CN101514232B RANKL-Fc fusion protein, preparation method and application thereof |
| 06/19/2013 | CN101270380B Screening method for hybrid tumor cell monoclonal preparation |
| 06/18/2013 | US8466271 Regulatory elements |
| 06/18/2013 | US8466269 Covalent tethering of functional groups to proteins and substrates therefor |
| 06/18/2013 | US8466267 Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene |
| 06/18/2013 | US8466262 Variable region sequences of IL-31 monoclonal antibodies and methods of use |
| 06/18/2013 | US8466261 Therapeutic using a bispecific antibody |
| 06/18/2013 | US8466260 Anti-FcRH5 antibodies and immunoconjugates and methods of use |
| 06/18/2013 | US8466090 Development and use of fluorescent probes of unbound analytes |
| 06/18/2013 | US8465958 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 06/18/2013 | US8465949 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 06/18/2013 | US8465947 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae |
| 06/18/2013 | US8465946 Expression system for the antibiotic-free production of polypeptides |
| 06/18/2013 | US8465945 Method for production and use of mite group 1 proteins |
| 06/18/2013 | US8465942 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 06/18/2013 | US8465937 Methods for identifying B-clones which bind cell-surface antigens |
| 06/18/2013 | CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/18/2013 | CA2452849C Method for monitoring and modulating protein folding |
| 06/18/2013 | CA2446185C Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells |
| 06/18/2013 | CA2440028C Rearranged squamous cell carcinoma antigen genes ii |
| 06/18/2013 | CA2439042C Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 06/18/2013 | CA2418144C Urocortin proteins and uses thereof |
| 06/18/2013 | CA2415187C Dna vaccines encoding hiv accessory proteins |
| 06/18/2013 | CA2278523C Rna binding protein and binding site useful for expression of recombinant molecules |
| 06/13/2013 | WO2013086302A1 Fractionation of proteins and lipids from microalgae |
| 06/13/2013 | WO2013085893A1 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 06/13/2013 | WO2013084504A1 Method for predicting hypertension |
| 06/13/2013 | WO2013084371A1 Recombinant protein capable of binding specifically and rapidly to human cardiac troponin i |
| 06/13/2013 | WO2013082708A1 Cyclic peptide production |
| 06/13/2013 | WO2013041969A3 Didemnin biosynthetic gene cluster in tistrella mobilis |
| 06/13/2013 | WO2013026004A3 Antibodies that bind integrin alpha-v beta-8 |
| 06/13/2013 | US20130150560 AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOF |
| 06/13/2013 | US20130150554 Cell culture of growth factor-free adapted cells |
| 06/13/2013 | US20130150296 Albumin fusion proteins |
| 06/13/2013 | US20130149743 Method for enhancing luminescence intensity of clytin-ii |
| 06/13/2013 | US20130149741 Methods for improved production of bioactive wnt proteins |
| 06/13/2013 | US20130149740 Method for the production of a polymerized product |
| 06/13/2013 | US20130149698 Stable compositions for nucleic acid amplification and sequencing |
| 06/13/2013 | US20130149334 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/13/2013 | CA2858599A1 Cyclic peptide production |
| 06/12/2013 | EP2601217A2 Antibodies directed against il-17 |
| 06/12/2013 | EP2600891A2 Protein fusion constructs possessing thrombolytic and anticoagulant properties |
| 06/12/2013 | CN1942588B Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/12/2013 | CN1918297B Hansenula polymorpha gene coding for alpha 1,6-mannosyltransferase and process for the production of recombinant glycoproteins with hansenula polymorpha mutant strain deficient in the same |
| 06/12/2013 | CN1529753B Disease-associated protein |
| 06/12/2013 | CN1461310B ANtibodies that bind human interleukin-18 and methods of making and using |
| 06/12/2013 | CN103154243A Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain |
| 06/12/2013 | CN103154026A Antibodies directed against il-17 |
| 06/12/2013 | CN103146791A Method for hydrolyzing egg-white proteins by various proteases |
| 06/12/2013 | CN103146790A Method for preparing composite fiber by copolymerization of reconstructed feather protein/chitin |
| 06/12/2013 | CN103146789A Preparation method of collagen |